CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,886,717 | +7.7% | 69,250 | -12.1% | 0.04% | +17.6% |
| Q2 2023 | $1,752,455 | +8.2% | 78,762 | +5.4% | 0.03% | +9.7% |
| Q1 2023 | $1,619,064 | +8.2% | 74,749 | +1.5% | 0.03% | +6.9% |
| Q4 2022 | $1,496,056 | -17.9% | 73,661 | +3.7% | 0.03% | -19.4% |
| Q3 2022 | $1,823,000 | +8.3% | 71,058 | +0.4% | 0.04% | +16.1% |
| Q2 2022 | $1,683,000 | +442.9% | 70,752 | +415.5% | 0.03% | +520.0% |
| Q1 2022 | $310,000 | -76.6% | 13,724 | -79.5% | 0.01% | -70.6% |
| Q4 2021 | $1,327,000 | +4.2% | 66,966 | +3.6% | 0.02% | 0.0% |
| Q3 2021 | $1,273,000 | – | 64,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |